 |
PDBsum entry 1bls
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase (acting in cyclic amides)
|
PDB id
|
|
|
|
1bls
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
33:6762-6772
(1994)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: mechanistic interpretation of a beta-lactamase transition-state analog.
|
|
E.Lobkovsky,
E.M.Billings,
P.C.Moews,
J.Rahil,
R.F.Pratt,
J.R.Knox.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The crystal structure of a complex formed on reaction of the Enterobacter
cloacae P99 cephalosporinase (beta-lactamase) with a phosphonate monoester
inhibitor, m-carboxyphenyl [[N-[(p-iodophenyl)acetyl]amino]methyl]phosphonate,
has been obtained at 2.3-A resolution. The structure shows that the inhibitor
has phosphonylated the active site serine (Ser64) with loss of the
m-carboxyphenol leaving group. The inhibitor is positioned in the active site in
a way that can be interpreted in terms of a transition-state analog. The
arylacetamido side chain is placed as anticipated from analogous beta-lactamoyl
complexes of penicillin-recognizing enzymes, with the amino group
hydrogen-bonded to the backbone carbonyl of Ser318 (of the B3 beta-strand) and
to the amides of Gln120 and Asn152. There is support in the asymmetry of the
hydrogen bonding of this side chain to the protein and in the 2-fold disorder of
the benzyl group for the considerable breadth in substrate specificity exhibited
by class C beta-lactamases. One phosphonyl oxygen atom is in the oxyanion hole,
hydrogen-bonded to main-chain NH groups of Ser318 and Ser64, while the other
oxygen is solvated, not within hydrogen-bonding distance of any amino acid side
chain. The closest active site functional group to the solvated oxygen atom is
the Tyr150 hydroxyl group (3.4A); Lys67 and Lys315 are quite distant (4.3 and
5.7 A, respectively). Rather, Tyr150 and Lys67 are more closely associated with
Ser64O gamma (2.9 and 3.3 A). This arrangement is interpreted in terms of the
transition state for breakdown of the tetrahedral intermediate in the
deacylation step of catalysis, where the Tyr150 phenol seems the most likely
general acid. Thus, Tyr150, as the phenoxide anion, would be the general base
catalyst in acylation, as proposed by Oefner et al. [Nature (1990) 343,
284-288]. The structure is compared with that of a similar phosphonate
derivative of a class A beta-lactamase [Chen et al. (1993) J. Mol. Biol. 234,
165-178], and mechanistic comparisons are made. The sensitivity of serine
beta-lactamases, as opposed to serine proteinases, toward inhibition by
phosphonate monoanions is supported by electrostatic calculations showing a net
positive potential only in the catalytic sites of the beta-lactamases.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Bebrone,
P.Lassaux,
L.Vercheval,
J.S.Sohier,
A.Jehaes,
E.Sauvage,
and
M.Galleni
(2010).
Current challenges in antimicrobial chemotherapy: focus on beta-lactamase inhibition.
|
| |
Drugs,
70,
651-679.
|
 |
|
|
|
|
 |
R.Liu,
W.Teo,
S.Tan,
H.Feng,
P.Padmanabhan,
and
B.Xing
(2010).
Metallic nanoparticles bioassay for Enterobacter cloacae P99 beta-lactamase activity and inhibitor screening.
|
| |
Analyst,
135,
1031-1036.
|
 |
|
|
|
|
 |
S.A.Adediran,
D.Cabaret,
J.F.Lohier,
M.Wakselman,
and
R.F.Pratt
(2010).
Substituted aryl malonamates as new serine beta-lactamase substrates: structure-activity studies.
|
| |
Bioorg Med Chem,
18,
282-291.
|
 |
|
|
|
|
 |
S.M.Drawz,
M.Babic,
C.R.Bethel,
M.Taracila,
A.M.Distler,
C.Ori,
E.Caselli,
F.Prati,
and
R.A.Bonomo
(2010).
Inhibition of the class C beta-lactamase from Acinetobacter spp.: insights into effective inhibitor design.
|
| |
Biochemistry,
49,
329-340.
|
 |
|
|
|
|
 |
S.M.Drawz,
and
R.A.Bonomo
(2010).
Three decades of beta-lactamase inhibitors.
|
| |
Clin Microbiol Rev,
23,
160-201.
|
 |
|
|
|
|
 |
A.Pavelka,
E.Chovancova,
and
J.Damborsky
(2009).
HotSpot Wizard: a web server for identification of hot spots in protein engineering.
|
| |
Nucleic Acids Res,
37,
W376-W383.
|
 |
|
|
|
|
 |
S.Majumdar,
and
R.F.Pratt
(2009).
Inhibition of class A and C beta-lactamases by diaroyl phosphates.
|
| |
Biochemistry,
48,
8285-8292.
|
 |
|
|
|
|
 |
Y.Chen,
A.McReynolds,
and
B.K.Shoichet
(2009).
Re-examining the role of Lys67 in class C beta-lactamase catalysis.
|
| |
Protein Sci,
18,
662-669.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
C.R.Bethel,
A.M.Distler,
M.W.Ruszczycky,
M.P.Carey,
P.R.Carey,
A.M.Hujer,
M.Taracila,
M.S.Helfand,
J.M.Thomson,
M.Kalp,
V.E.Anderson,
D.A.Leonard,
K.M.Hujer,
T.Abe,
A.M.Venkatesan,
T.S.Mansour,
and
R.A.Bonomo
(2008).
Inhibition of OXA-1 beta-lactamase by penems.
|
| |
Antimicrob Agents Chemother,
52,
3135-3143.
|
 |
|
|
|
|
 |
C.Urbach,
J.Fastrez,
and
P.Soumillion
(2008).
A New Family of Cyanobacterial Penicillin-binding Proteins: A MISSING LINK IN THE EVOLUTION OF CLASS A {beta}-LACTAMASES.
|
| |
J Biol Chem,
283,
32516-32526.
|
 |
|
|
|
|
 |
R.B.Pelto,
and
R.F.Pratt
(2008).
Kinetics and mechanism of inhibition of a serine beta-lactamase by O-aryloxycarbonyl hydroxamates.
|
| |
Biochemistry,
47,
12037-12046.
|
 |
|
|
|
|
 |
S.Morandi,
F.Morandi,
E.Caselli,
B.K.Shoichet,
and
F.Prati
(2008).
Structure-based optimization of cephalothin-analogue boronic acids as beta-lactamase inhibitors.
|
| |
Bioorg Med Chem,
16,
1195-1205.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
G.S.Shukla,
C.J.Murray,
M.Estabrook,
G.P.Shen,
V.Schellenberger,
and
D.N.Krag
(2007).
Towards a ligand targeted enzyme prodrug therapy: single round panning of a beta-lactamase scaffold library on human cancer cells.
|
| |
Int J Cancer,
120,
2233-2242.
|
 |
|
|
|
|
 |
Y.Chen,
G.Minasov,
T.A.Roth,
F.Prati,
and
B.K.Shoichet
(2006).
The deacylation mechanism of AmpC beta-lactamase at ultrahigh resolution.
|
| |
J Am Chem Soc,
128,
2970-2976.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Fenollar-Ferrer,
J.Donoso,
J.Frau,
and
F.Muñoz
(2005).
Molecular modeling of Henry-Michaelis and acyl-enzyme complexes between imipenem and Enterobacter cloacae P99 beta-lactamase.
|
| |
Chem Biodivers,
2,
645-656.
|
 |
|
|
|
|
 |
Y.Chen,
B.Shoichet,
and
R.Bonnet
(2005).
Structure, function, and inhibition along the reaction coordinate of CTX-M beta-lactamases.
|
| |
J Am Chem Soc,
127,
5423-5434.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.Nukaga,
S.Kumar,
K.Nukaga,
R.F.Pratt,
and
J.R.Knox
(2004).
Hydrolysis of third-generation cephalosporins by class C beta-lactamases. Structures of a transition state analog of cefotoxamine in wild-type and extended spectrum enzymes.
|
| |
J Biol Chem,
279,
9344-9352.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.H.Georgopapadakou
(2004).
Beta-lactamase inhibitors: evolving compounds for evolving resistance targets.
|
| |
Expert Opin Investig Drugs,
13,
1307-1318.
|
 |
|
|
|
|
 |
S.D.Goldberg,
W.Iannuccilli,
T.Nguyen,
J.Ju,
and
V.W.Cornish
(2003).
Identification of residues critical for catalysis in a class C beta-lactamase by combinatorial scanning mutagenesis.
|
| |
Protein Sci,
12,
1633-1645.
|
 |
|
|
|
|
 |
T.A.Roth,
G.Minasov,
S.Morandi,
F.Prati,
and
B.K.Shoichet
(2003).
Thermodynamic cycle analysis and inhibitor design against beta-lactamase.
|
| |
Biochemistry,
42,
14483-14491.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.M.Beadle,
and
B.K.Shoichet
(2002).
Structural basis for imipenem inhibition of class C beta-lactamases.
|
| |
Antimicrob Agents Chemother,
46,
3978-3980.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
B.M.Beadle,
I.Trehan,
P.J.Focia,
and
B.K.Shoichet
(2002).
Structural milestones in the reaction pathway of an amide hydrolase: substrate, acyl, and product complexes of cephalothin with AmpC beta-lactamase.
|
| |
Structure,
10,
413-424.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.A.Powers,
F.Morandi,
and
B.K.Shoichet
(2002).
Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase.
|
| |
Structure,
10,
1013-1023.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
U.G.Wagner,
E.I.Petersen,
H.Schwab,
and
C.Kratky
(2002).
EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity.
|
| |
Protein Sci,
11,
467-478.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
D.Tondi,
R.A.Powers,
E.Caselli,
M.C.Negri,
J.Blázquez,
M.P.Costi,
and
B.K.Shoichet
(2001).
Structure-based design and in-parallel synthesis of inhibitors of AmpC beta-lactamase.
|
| |
Chem Biol,
8,
593-611.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
E.Caselli,
R.A.Powers,
L.C.Blasczcak,
C.Y.Wu,
F.Prati,
and
B.K.Shoichet
(2001).
Energetic, structural, and antimicrobial analyses of beta-lactam side chain recognition by beta-lactamases.
|
| |
Chem Biol,
8,
17-31.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.V.Crichlow,
M.Nukaga,
V.R.Doppalapudi,
J.D.Buynak,
and
J.R.Knox
(2001).
Inhibition of class C beta-lactamases: structure of a reaction intermediate with a cephem sulfone.
|
| |
Biochemistry,
40,
6233-6239.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
I.Trehan,
B.M.Beadle,
and
B.K.Shoichet
(2001).
Inhibition of AmpC beta-lactamase through a destabilizing interaction in the active site.
|
| |
Biochemistry,
40,
7992-7999.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Wouters,
P.Charlier,
D.Monnaie,
J.M.Frère,
and
E.Fonzé
(2001).
Expression, purification, crystallization and preliminary X-ray analysis of the native class C beta-lactamase from Enterobacter cloacae 908R and two mutants.
|
| |
Acta Crystallogr D Biol Crystallogr,
57,
162-164.
|
 |
|
|
|
|
 |
R.A.Powers,
E.Caselli,
P.J.Focia,
F.Prati,
and
B.K.Shoichet
(2001).
Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.
|
| |
Biochemistry,
40,
9207-9214.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Kato-Toma,
and
M.Ishiguro
(2001).
Reaction of Lys-Tyr-Lys triad mimics with benzylpenicillin: insight into the role of Tyr150 in class C beta-lactamase.
|
| |
Bioorg Med Chem Lett,
11,
1161-1164.
|
 |
|
|
|
|
 |
J.Lamotte-Brasseur,
A.Dubus,
and
R.C.Wade
(2000).
pK(a) calculations for class C beta-lactamases: the role of Tyr-150.
|
| |
Proteins,
40,
23-28.
|
 |
|
|
|
|
 |
M.G.Page
(2000).
b-Lactamase inhibitors.
|
| |
Drug Resist Updat,
3,
109-125.
|
 |
|
|
|
|
 |
M.Inoue,
J.Hiratake,
H.Suzuki,
H.Kumagai,
and
K.Sakata
(2000).
Identification of catalytic nucleophile of Escherichia coli gamma-glutamyltranspeptidase by gamma-monofluorophosphono derivative of glutamic acid: N-terminal thr-391 in small subunit is the nucleophile.
|
| |
Biochemistry,
39,
7764-7771.
|
 |
|
|
|
|
 |
B.M.Beadle,
S.L.McGovern,
A.Patera,
and
B.K.Shoichet
(1999).
Functional analyses of AmpC beta-lactamase through differential stability.
|
| |
Protein Sci,
8,
1816-1824.
|
 |
|
|
|
|
 |
R.A.Powers,
J.Blázquez,
G.S.Weston,
M.I.Morosini,
F.Baquero,
and
B.K.Shoichet
(1999).
The complexed structure and antimicrobial activity of a non-beta-lactam inhibitor of AmpC beta-lactamase.
|
| |
Protein Sci,
8,
2330-2337.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.A.Adediran,
and
R.F.Pratt
(1999).
Beta-secondary and solvent deuterium kinetic isotope effects on catalysis by the Streptomyces R61 DD-peptidase: comparisons with a structurally similar class C beta-lactamase.
|
| |
Biochemistry,
38,
1469-1477.
|
 |
|
|
|
|
 |
S.Trépanier,
J.R.Knox,
N.Clairoux,
F.Sanschagrin,
R.C.Levesque,
and
A.Huletsky
(1999).
Structure-function studies of Ser-289 in the class C beta-lactamase from Enterobacter cloacae P99.
|
| |
Antimicrob Agents Chemother,
43,
543-548.
|
 |
|
|
|
|
 |
Y.Sakai,
J.Ishikawa,
S.Fukasaka,
H.Yurimoto,
R.Mitsui,
H.Yanase,
and
N.Kato
(1999).
A new carboxylesterase from Brevibacterium linens IFO 12171 responsible for the conversion of 1,4-butanediol diacrylate to 4-hydroxybutyl acrylate: purification, characterization, gene cloning, and gene expression in Escherichia coli.
|
| |
Biosci Biotechnol Biochem,
63,
688-697.
|
 |
|
|
|
|
 |
I.Massova,
and
S.Mobashery
(1998).
Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases.
|
| |
Antimicrob Agents Chemother,
42,
1.
|
 |
|
|
|
|
 |
S.Banerjee,
U.Pieper,
G.Kapadia,
L.K.Pannell,
and
O.Herzberg
(1998).
Role of the omega-loop in the activity, substrate specificity, and structure of class A beta-lactamase.
|
| |
Biochemistry,
37,
3286-3296.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
N.Li,
J.Rahil,
M.E.Wright,
and
R.F.Pratt
(1997).
Structure-activity studies of the inhibition of serine beta-lactamases by phosphonate monoesters.
|
| |
Bioorg Med Chem,
5,
1783-1788.
|
 |
|
|
|
|
 |
S.Banerjee,
N.Shigematsu,
L.K.Pannell,
S.Ruvinov,
J.Orban,
F.Schwarz,
and
O.Herzberg
(1997).
Probing the non-proline cis peptide bond in beta-lactamase from Staphylococcus aureus PC1 by the replacement Asn136 --> Ala.
|
| |
Biochemistry,
36,
10857-10866.
|
 |
|
|
|
|
 |
C.C.Chen,
T.J.Smith,
G.Kapadia,
S.Wäsch,
L.E.Zawadzke,
A.Coulson,
and
O.Herzberg
(1996).
Structure and kinetics of the beta-lactamase mutants S70A and K73H from Staphylococcus aureus PC1.
|
| |
Biochemistry,
35,
12251-12258.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.E.Zawadzke,
C.C.Chen,
S.Banerjee,
Z.Li,
S.Wäsch,
G.Kapadia,
J.Moult,
and
O.Herzberg
(1996).
Elimination of the hydrolytic water molecule in a class A beta-lactamase mutant: crystal structure and kinetics.
|
| |
Biochemistry,
35,
16475-16482.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
N.O.Siemers,
D.E.Yelton,
J.Bajorath,
and
P.D.Senter
(1996).
Modifying the specificity and activity of the Enterobacter cloacae P99 beta-lactamase by mutagenesis within an M13 phage vector.
|
| |
Biochemistry,
35,
2104-2111.
|
 |
|
|
|
|
 |
S.A.Adediran,
S.A.Deraniyagala,
Y.Xu,
and
R.F.Pratt
(1996).
Beta-secondary and solvent deuterium kinetic isotope effects on beta-lactamase catalysis.
|
| |
Biochemistry,
35,
3604-3613.
|
 |
|
|
|
|
 |
J.M.Frère
(1995).
Beta-lactamases and bacterial resistance to antibiotics.
|
| |
Mol Microbiol,
16,
385-395.
|
 |
|
|
|
|
 |
J.R.Knox
(1995).
Extended-spectrum and inhibitor-resistant TEM-type beta-lactamases: mutations, specificity, and three-dimensional structure.
|
| |
Antimicrob Agents Chemother,
39,
2593-2601.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |